Mary Miller - 01 Oct 2025 Form 4 Insider Report for Acrivon Therapeutics, Inc. (ACRV)

Signature
/s/ Adam D. Levy, Attorney-in-Fact
Issuer symbol
ACRV
Transactions as of
01 Oct 2025
Net transactions value
-$514
Form type
4
Filing time
03 Oct 2025, 16:26:35 UTC
Previous filing
18 Aug 2025
Next filing
21 Oct 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Miller Mary Chief Legal Officer C/O ACRIVON THERAPEUTICS, INC., 480 ARSENAL WAY, SUITE 100, WATERTOWN /s/ Adam D. Levy, Attorney-in-Fact 03 Oct 2025 0001841088

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACRV Common Stock Tax liability $514 -284 -0.8% $1.81 35,297 01 Oct 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.